Show simple item record

In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA : An Encouraging Milestone to Further Clinical Drug Development

dc.contributor.authorUbah, Obinna
dc.contributor.authorPorter, Andrew J
dc.contributor.authorBarelle, Caroline J
dc.date.accessioned2020-02-04T15:20:01Z
dc.date.available2020-02-04T15:20:01Z
dc.date.issued2020-02-03
dc.identifier.citationUbah , O , Porter , A J & Barelle , C J 2020 , ' In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA : An Encouraging Milestone to Further Clinical Drug Development ' , Journal of Immunology Research , vol. 2020 , 7283239 , pp. 7283239 . https://doi.org/10.1155/2020/7283239en
dc.identifier.issn2314-7156
dc.identifier.otherPURE: 155763580
dc.identifier.otherPURE UUID: 71d480ac-0f2f-4c0f-bfdb-12e960b1d5da
dc.identifier.otherPubMed: 32090129
dc.identifier.otherScopus: 85079741293
dc.identifier.otherWOS: 000515768700001
dc.identifier.urihttps://hdl.handle.net/2164/13655
dc.descriptionCopyright © 2020 Obinna C. Ubah et al.en
dc.format.extent14
dc.language.isoeng
dc.relation.ispartofJournal of Immunology Researchen
dc.rightsCopyright © 2020 Obinna C. Ubah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/en
dc.subjectANTI-ADALIMUMAB ANTIBODIESen
dc.subjectTNF THERAPYen
dc.subjectINTERFERENCEen
dc.subjectMECHANISMSen
dc.subjectINFLIXIMABen
dc.subjectDISEASESen
dc.subjectR Medicineen
dc.subjectImmunology and Allergyen
dc.subjectImmunologyen
dc.subjectBiotechnology and Biological Sciences Research Council (BBSRC)en
dc.subjectBB/K010905/1en
dc.subject.lccRen
dc.titleIn Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA : An Encouraging Milestone to Further Clinical Drug Developmenten
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1155/2020/7283239
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85079741293&partnerID=8YFLogxKen


Files in this item

Thumbnail
Name:
Ubah_etal_JImmRes_Invitro_VOR.pdf
Size:
1.436Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record